You have the correct answer,skweze. Witness the multiple class action suits brought by numerous shareholders against BMY/MEDX because MEDX board agreed to BMY TO's serious undervaluation of MEDX shares at $16/share. Consolidated in N.J at the time, both state and Federal---the latter deferred to J.Jacobsen in state court in Trenton.Bungler and hump4 can confirm deails.
A number of us here were deprived of serious money on that one.
A cheap buyout is my main concern regarding PPHM. Me, just like some of you , have also suffered a "cheap" buyout of anothe Co. I was a shareholder. The buyout was terrible for shareholders but I suppose great for the BoD. This is a point that we shareholders should focus on and take the necessary steps for that not to happen. Which ones? I dont know
News 
Market Data 
Discover 
AI
